The Cytel Blog: Perspectives on Enquiry & Evidence

Data Monitoring Committees (DMCs) are groups of independent experts who periodically receive (by-arm) reports created..

At the 2019 Challenges in Rare Diseases Clinical Trials Symposium and East training, Cytel partnered with Alexion to..

With adaptive and innovative trial designs on the rise, operational implementation of interim analyses, including..

While adaptive designs can deliver significant benefits to clinical development-  including ethical benefits for..

In the 2010 draft FDA ‘Guidance for Industry on Adaptive Design Clinical Trials for Drugs and Biologics',  the agency..

At the recent JSM Meeting, Cytel’s Yannis Jemiai presented the case study of the VALOR trial which used a promising..

 Predicting the course of a clinical trial is something which people will always want to do-whether for statistical..

At Cytel, we are very often asked to get involved in DMCs ( Data Monitoring Committees)  in a variety of capacities...